Pomerantz LLP

GPGI, Inc.
Securities Class Action

Company Name: GPGI, Inc. (GPGI)

Download Complaint
Class Period

November 3, 2025 - May 6, 2026

Motion Deadline

September 15, 2026|61 days left

Please submit the form below if you believe you have incurred losses.

Investment Details

Transactions Information

Select a file or drag and drop here

PDF, XLS, or CSV, file size no more than 25MB

By clicking the submit button above, I acknowledge that this form is not intended to and does not establish an attorney-client relationship between myself and Pomerantz LLP ("Pomerantz" or "The Firm"), and that the submission or receipt of information to the Firm or one of its attorneys via this form, website, e-mail or telephone does not create an attorney-client relationship. Prior results do not guarantee a similar outcome in future cases.

Pomerantz LLP does not share your information with others. There is no cost or obligation for you to submit. By submitting this form, you are authorizing us to contact you regarding this case and/or future cases.

Allegations

On March 12, 2026, GPGI announced 4Q25 and FY25 earnings and disclosed that its Husky Technologies reporting segment had $520.8 million in 4Q25 net sales (up 6.1% year-over-year) and $1.5687 billion in FY25 net sales (up 5% year-over-year). GPGI further disclosed that Husky had Pro Forma Adjusted EBITDA of $136.1 million in 4Q25 (down 5.4% year-over-year) and $373.4 million in FY25 (down 3% year-over-year). Notably, Husky’s Pro Forma Adjusted EBITDA margins for 4Q25 compressed by 318 basis points from 29.3% to 26.1%. On this news, GPGI’s stock price fell $3.23 per share, or 16.36%, over two trading sessions, to close at $16.51 per share on March 13, 2026. Then, on May 7, 2026, GPGI reported its 1Q26 financial results, revealing that Husky’s Pro Forma Adjusted Net Sales were just $290.8 million, down 5.2% year-over-year, and its Pro Forma Adjusted EBITDA fell to $38 million, down 40.2% year-over year. Additionally, GPGI cut 2026 guidance, with its Pro Forma Adjusted Net Sales lowered from an initial range of $2.183 billion to $2.228 billion to a range of $1.95 billion to $2.10 billion, and its Pro Forma Adjusted EBITDA lowered from an initial range of $620 million to $650 million to a range of $550 million to $610 million. On this news, GPGI’s stock price fell $4.52 per share, or 25.89%, to close at $12.94 per share on May 7, 2026.

Lead Plaintiff

If you have qualifying losses, you may be eligible to serve as Lead Plaintiff. Acting as a representative for all class members seeking recovery in the lawsuit, the Lead Plaintiff plays an important role in the litigation, including selecting a law firm to serve as Lead Counsel and approving the final settlement. There is no cost whatsoever to seek or participate as a Lead Plaintiff. The Lead Plaintiff may also receive a monetary award for their participation in the suit.

About the Firm

Founded in 1936, Pomerantz LLP is the oldest law firm in the world dedicated to championing investor rights. Throughout its history, the Firm has won landmark decisions that have initiated historic corporate governance reforms and shaped the law to better protect shareholders. Pomerantz has successfully resolved hundreds of securities class actions as Lead Counsel, recovering billions of dollars on behalf of defrauded investors with many settlements breaking previously held records. Pomerantz is headquartered in New York City, with offices in Los Angeles, Chicago, Paris, London, and Tel Aviv.